Riskpilot← Back to searchSign inGet full accessVMS Medical consulting AB
ABActiveOrg 5592914682Granhultsliden 7Medical specialists activities · NACE 8622Est. 20201 employees
Revenue 2024
SEK 1,4M
-19% vs 2023
EBITDA margin
10.6%
-52% vs 2023
Equity ratio
41.0%
Financial strength
Net profit 2024
SEK 115K
-38% vs 2023
| Revenue | SEK 1,4M | -19% |
| EBITDA | SEK 150K | -52% |
| Net profit | SEK 115K | -38% |
| Total assets | SEK 1M | -9% |
| Equity | SEK 424K | -17% |
| Employees | 1 | — |
Legal name
VMS Medical consulting AB
Org number
5592914682
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
17 december 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Aktiebolaget ska utföra medicinsk rådgivning både digitalt och på plats, hyra ut personal.
Address
Granhultsliden 7
Email
vic.shah@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 688 | 1 638 | 1 739 | 1 416 |
| Staff expenses | — | −1 130 | −1 384 | −1 174 |
| EBITDA | 330 | 344 | 315 | 150 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | 330 | 344 | 315 | 150 |
| Net financials | −1 | −0 | −1 | −3 |
| Profit before tax | 247 | 258 | 234 | 148 |
| Tax | −53 | −53 | −49 | −32 |
| Net profit | 194 | 204 | 185 | 115 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 464 | 894 | 1 142 | 1 035 |
| Equity | 219 | 323 | 508 | 424 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 162 | 403 | 385 | 363 |
| Total debt | 162 | 403 | 385 | 363 |
EBITDA margin
10.6%
This company
15.8%
Market median
-33% vs market
20212024
Equity ratio
41.0%
This company
38.2%
Market median
+7% vs market
20212024
Return on equity
27.2%
This company
18.4%
Market median
+48% vs market
20212024
Net profit margin
8.2%
This company
8.1%
Market median
+1% vs market
20212024
Asset turnover
1.37×
This company
1.12×
Market median
+22% vs market
20212024
Debt / equity
1.44×
This company
0.62×
Market median
-132% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Deputy Board Member | 2025 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VMS Medical consulting AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Lennart Norberg | Board of Directors | 0 companies |
| Victor Moulik Shah | Chairman | 0 companies |
| Karin Johanna Maria Almström | Deputy Board Member | 0 companies |
| Mahboob Ather Khawdja Butt | Deputy Board Member | 0 companies |